Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 47Inflammatory Breast Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Ovarian Neoplasms 2Obesity 2Neoplasm Metastasis 2Central Nervous System Neoplasms 2Breast Carcinoma In Situ 2Breast Cancer Female 2Vitamin D Deficiency 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Sleep Wake Disorders 1Sexuality 1Recurrence 1Pulmonary Fibrosis 1Nutrition Disorders 1Neoplasms 1Melanoma 1Hormone-receptor-positive Breast Cancer 1Gliosarcoma 1Glioblastoma 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1ER+ Breast Cancer 1Carcinoma, Ovarian Epithelial 1Breast Diseases 1Breast Cancer Patients in Premenopausal 1Breast Cancer Organoids 1Astrocytoma 1

Interventions

Cyclophosphamide 17fludarabine 13Dexamethasone 12Cisplatin 12Rituximab 10Gemcitabine 9Paclitaxel 8Bendamustine Hydrochloride 8Lenalidomide 7Decitabine 7Cytarabine 7Carboplatin 7fludarabine phosphate 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Etoposide 6Bortezomib 6Radiotherapy 5Injections 5Azacitidine 5camrelizumab 4apatinib 4Valproic Acid 4Thalidomide 4Procarbazine 4Oxaliplatin 4Drug Therapy 4Bevacizumab 4Antilymphocyte Serum 4venetoclax 3pomalidomide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Recurrence × Tamoxifen × Clear all
NCT04666805 2020-12-14

Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

First Hospital of China Medical University

Unknown
1,354 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡